News Headlines Article

Alzheimer’s drugs are expensive, and they don’t work very well for most people
Washington Post

More than 5 million people in the United States have Alzheimer’s disease, an insidious disorder that gradually destroys the brain, robbing people of the ability to remember, complete everyday tasks and function on their own. Several drugs are approved to treat it, including donepezil (Aricept and its generic cousins) and memantine (Namenda). But they don’t work well for most people, according to a report from Consumer Reports Best Buy Drugs. In fact, the report concluded that none of the drugs could be recommended as a Best Buy.